Skip to main content
Top
Published in: Critical Care 1/2011

Open Access 01-02-2011 | Research

Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients

Authors: Alexander Koch, Sebastian Voigt, Edouard Sanson, Hanna Dückers, Andreas Horn, Henning W Zimmermann, Christian Trautwein, Frank Tacke

Published in: Critical Care | Issue 1/2011

Login to get access

Abstract

Introduction

C-type natriuretic peptide (CNP) is a paracrine molecule which is mainly synthesized in the vasculature. High levels have been reported in sepsis, and CNP has been proposed as a biomarker predicting sepsis in traumatized patients. We aimed at evaluating the diagnostic and prognostic value of N-terminal pro-CNP (NT-proCNP) for predicting sepsis, disease severity and mortality in critically ill medical patients.

Methods

273 critically ill patients (197 patients with sepsis or septic shock, 76 without evidence of sepsis) and 43 healthy controls were consecutively included in a prospective clinical single-center non-interventional study at the Medical Intensive Care Unit, RWTH-University Aachen, Germany. Patients' outcome was followed for about 1 year. NT-proCNP serum concentrations were determined upon ICU admission, as well as in the mornings of day 3 and day 7 after admission. Intensive care treatment measures as well as routine and experimental laboratory parameters were recorded and analyzed.

Results

NT-proCNP serum concentrations upon admission to the ICU were elevated in critically ill patients as compared with healthy controls. Patients with sepsis had significantly higher NT-proCNP levels than non-sepsis patients. NT-proCNP was strongly associated with inflammatory parameters (i.e. C-reactive protein, procalcitonin and TNF-α), biomarkers of organ dysfunction and clinical composite scores (APACHE-II, SOFA, SAPS2). NT-proCNP levels at admission and day 3 were found to be a strong predictive marker for ICU- and overall survival. Moreover, a decline of serum NT-proCNP after admission to the ICU was associated with reduced mortality. The predictive power of serum NT-proCNP was similar to 'conventional' prognostic tools such as clinical scores.

Conclusions

NT-proCNP is significantly elevated in critically ill patients, with highest levels in sepsis. Inflammation as well as organ function are strongly associated with NT-proCNP serum concentrations. Low initial NT-proCNP levels and a decline during initial treatment indicate a favourable ICU- and long-term outcome.
Appendix
Available only for authorised users
Literature
1.
go back to reference Nakao K, Ogawa Y, Suga S, Imura H: Molecular biology and biochemistry of the natriuretic peptide system. II: Natriuretic peptide receptors. J Hypertens 1992, 10: 1111-1114. 10.1097/00004872-199210000-00002PubMedCrossRef Nakao K, Ogawa Y, Suga S, Imura H: Molecular biology and biochemistry of the natriuretic peptide system. II: Natriuretic peptide receptors. J Hypertens 1992, 10: 1111-1114. 10.1097/00004872-199210000-00002PubMedCrossRef
2.
go back to reference Rubattu S, Sciarretta S, Valenti V, Stanzione R, Volpe M: Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am J Hypertens 2008, 21: 733-741. 10.1038/ajh.2008.174PubMedCrossRef Rubattu S, Sciarretta S, Valenti V, Stanzione R, Volpe M: Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am J Hypertens 2008, 21: 733-741. 10.1038/ajh.2008.174PubMedCrossRef
3.
go back to reference Suttner SW, Boldt J: Natriuretic peptide system: physiology and clinical utility. Curr Opin Crit Care 2004, 10: 336-341. 10.1097/01.ccx.0000135513.26376.4fPubMedCrossRef Suttner SW, Boldt J: Natriuretic peptide system: physiology and clinical utility. Curr Opin Crit Care 2004, 10: 336-341. 10.1097/01.ccx.0000135513.26376.4fPubMedCrossRef
4.
go back to reference Brueckmann M, Huhle G, Lang S, Haase KK, Bertsch T, Weiss C, Kaden JJ, Putensen C, Borggrefe M, Hoffmann U: Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 2005, 112: 527-534. 10.1161/CIRCULATIONAHA.104.472050PubMedCrossRef Brueckmann M, Huhle G, Lang S, Haase KK, Bertsch T, Weiss C, Kaden JJ, Putensen C, Borggrefe M, Hoffmann U: Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 2005, 112: 527-534. 10.1161/CIRCULATIONAHA.104.472050PubMedCrossRef
5.
go back to reference Varpula M, Pulkki K, Karlsson S, Ruokonen E, Pettila V: Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock. Crit Care Med 2007, 35: 1277-1283. 10.1097/01.CCM.0000261893.72811.0FPubMedCrossRef Varpula M, Pulkki K, Karlsson S, Ruokonen E, Pettila V: Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock. Crit Care Med 2007, 35: 1277-1283. 10.1097/01.CCM.0000261893.72811.0FPubMedCrossRef
6.
go back to reference Wu C, Wu F, Pan J, Morser J, Wu Q: Furin-mediated processing of Pro-C-type natriuretic peptide. J Biol Chem 2003, 278: 25847-25852. 10.1074/jbc.M301223200PubMedCrossRef Wu C, Wu F, Pan J, Morser J, Wu Q: Furin-mediated processing of Pro-C-type natriuretic peptide. J Biol Chem 2003, 278: 25847-25852. 10.1074/jbc.M301223200PubMedCrossRef
7.
go back to reference Vlachopoulos C, Ioakeimidis N, Terentes-Printzios D, Aznaouridis K, Baou K, Bratsas A, Lazaros G, Stefanadis C: Amino-terminal pro-C-type natriuretic peptide is associated with arterial stiffness, endothelial function and early atherosclerosis. Atherosclerosis 2010, 211: 649-655. 10.1016/j.atherosclerosis.2010.03.020PubMedCrossRef Vlachopoulos C, Ioakeimidis N, Terentes-Printzios D, Aznaouridis K, Baou K, Bratsas A, Lazaros G, Stefanadis C: Amino-terminal pro-C-type natriuretic peptide is associated with arterial stiffness, endothelial function and early atherosclerosis. Atherosclerosis 2010, 211: 649-655. 10.1016/j.atherosclerosis.2010.03.020PubMedCrossRef
8.
go back to reference Sudoh T, Minamino N, Kangawa K, Matsuo H: Brain natriuretic peptide-32: N-terminal six amino acid extended form of brain natriuretic peptide identified in porcine brain. Biochem Biophys Res Commun 1988, 155: 726-732. 10.1016/S0006-291X(88)80555-2PubMedCrossRef Sudoh T, Minamino N, Kangawa K, Matsuo H: Brain natriuretic peptide-32: N-terminal six amino acid extended form of brain natriuretic peptide identified in porcine brain. Biochem Biophys Res Commun 1988, 155: 726-732. 10.1016/S0006-291X(88)80555-2PubMedCrossRef
9.
go back to reference Komatsu Y, Nakao K, Suga S, Ogawa Y, Mukoyama M, Arai H, Shirakami G, Hosoda K, Nakagawa O, Hama N, et al.: C-type natriuretic peptide (CNP) in rats and humans. Endocrinology 1991, 129: 1104-1106. 10.1210/endo-129-2-1104PubMedCrossRef Komatsu Y, Nakao K, Suga S, Ogawa Y, Mukoyama M, Arai H, Shirakami G, Hosoda K, Nakagawa O, Hama N, et al.: C-type natriuretic peptide (CNP) in rats and humans. Endocrinology 1991, 129: 1104-1106. 10.1210/endo-129-2-1104PubMedCrossRef
10.
go back to reference Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H: Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system". J Clin Invest 1992, 90: 1145-1149. 10.1172/JCI115933PubMedPubMedCentralCrossRef Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H: Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system". J Clin Invest 1992, 90: 1145-1149. 10.1172/JCI115933PubMedPubMedCentralCrossRef
11.
go back to reference Hagiwara H, Sakaguchi H, Itakura M, Yoshimoto T, Furuya M, Tanaka S, Hirose S: Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B. J Biol Chem 1994, 269: 10729-10733.PubMed Hagiwara H, Sakaguchi H, Itakura M, Yoshimoto T, Furuya M, Tanaka S, Hirose S: Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B. J Biol Chem 1994, 269: 10729-10733.PubMed
12.
go back to reference Schulz S: C-type natriuretic peptide and guanylyl cyclase B receptor. Peptides 2005, 26: 1024-1034. 10.1016/j.peptides.2004.08.027PubMedCrossRef Schulz S: C-type natriuretic peptide and guanylyl cyclase B receptor. Peptides 2005, 26: 1024-1034. 10.1016/j.peptides.2004.08.027PubMedCrossRef
13.
go back to reference Scotland RS, Ahluwalia A, Hobbs AJ: C-type natriuretic peptide in vascular physiology and disease. Pharmacol Ther 2005, 105: 85-93. 10.1016/j.pharmthera.2004.08.011PubMedCrossRef Scotland RS, Ahluwalia A, Hobbs AJ: C-type natriuretic peptide in vascular physiology and disease. Pharmacol Ther 2005, 105: 85-93. 10.1016/j.pharmthera.2004.08.011PubMedCrossRef
14.
go back to reference Suga S, Itoh H, Komatsu Y, Ogawa Y, Hama N, Yoshimasa T, Nakao K: Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells--evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells. Endocrinology 1993, 133: 3038-3041. 10.1210/en.133.6.3038PubMed Suga S, Itoh H, Komatsu Y, Ogawa Y, Hama N, Yoshimasa T, Nakao K: Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells--evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells. Endocrinology 1993, 133: 3038-3041. 10.1210/en.133.6.3038PubMed
15.
go back to reference Barr CS, Rhodes P, Struthers AD: C-type natriuretic peptide. Peptides 1996, 17: 1243-1251. 10.1016/S0196-9781(96)00110-6PubMedCrossRef Barr CS, Rhodes P, Struthers AD: C-type natriuretic peptide. Peptides 1996, 17: 1243-1251. 10.1016/S0196-9781(96)00110-6PubMedCrossRef
16.
go back to reference Glauser MP, Zanetti G, Baumgartner JD, Cohen J: Septic shock: pathogenesis. Lancet 1991, 338: 732-736. 10.1016/0140-6736(91)91452-ZPubMedCrossRef Glauser MP, Zanetti G, Baumgartner JD, Cohen J: Septic shock: pathogenesis. Lancet 1991, 338: 732-736. 10.1016/0140-6736(91)91452-ZPubMedCrossRef
17.
go back to reference Hama N, Itoh H, Shirakami G, Suga S, Komatsu Y, Yoshimasa T, Tanaka I, Mori K, Nakao K: Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients. Biochem Biophys Res Commun 1994, 198: 1177-1182. 10.1006/bbrc.1994.1166PubMedCrossRef Hama N, Itoh H, Shirakami G, Suga S, Komatsu Y, Yoshimasa T, Tanaka I, Mori K, Nakao K: Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients. Biochem Biophys Res Commun 1994, 198: 1177-1182. 10.1006/bbrc.1994.1166PubMedCrossRef
18.
go back to reference Bahrami S, Pelinka L, Khadem A, Maitzen S, Hawa G, van Griensven M, Redl H: Circulating NT-proCNP predicts sepsis in multiple-traumatized patients without traumatic brain injury. Crit Care Med 2010, 38: 161-166. 10.1097/CCM.0b013e3181b78a06PubMedCrossRef Bahrami S, Pelinka L, Khadem A, Maitzen S, Hawa G, van Griensven M, Redl H: Circulating NT-proCNP predicts sepsis in multiple-traumatized patients without traumatic brain injury. Crit Care Med 2010, 38: 161-166. 10.1097/CCM.0b013e3181b78a06PubMedCrossRef
19.
go back to reference Gressner OA, Koch A, Sanson E, Trautwein C, Tacke F: High C5a levels are associated with increased mortality in sepsis patients--no enhancing effect by actin-free Gc-globulin. Clin Biochem 2008, 41: 974-980. 10.1016/j.clinbiochem.2008.05.005PubMedCrossRef Gressner OA, Koch A, Sanson E, Trautwein C, Tacke F: High C5a levels are associated with increased mortality in sepsis patients--no enhancing effect by actin-free Gc-globulin. Clin Biochem 2008, 41: 974-980. 10.1016/j.clinbiochem.2008.05.005PubMedCrossRef
20.
go back to reference Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101: 1644-1655. 10.1378/chest.101.6.1644PubMedCrossRef Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101: 1644-1655. 10.1378/chest.101.6.1644PubMedCrossRef
21.
go back to reference Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985, 13: 818-829. 10.1097/00003246-198510000-00009PubMedCrossRef Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985, 13: 818-829. 10.1097/00003246-198510000-00009PubMedCrossRef
22.
go back to reference Koch A, Sanson E, Helm A, Voigt S, Trautwein C, Tacke F: Regulation and prognostic relevance of serum ghrelin concentrations in critical illness and sepsis. Crit Care 2010, 14: R94. 10.1186/cc9029PubMedPubMedCentralCrossRef Koch A, Sanson E, Helm A, Voigt S, Trautwein C, Tacke F: Regulation and prognostic relevance of serum ghrelin concentrations in critical illness and sepsis. Crit Care 2010, 14: R94. 10.1186/cc9029PubMedPubMedCentralCrossRef
23.
go back to reference Koch A, Weiskirchen R, Sanson E, Zimmermann HW, Voigt S, Duckers H, Trautwein C, Tacke F: Circulating retinol binding protein 4 in critically ill patients before specific treatment: prognostic impact and correlation with organ function, metabolism and inflammation. Crit Care 2010, 14: R179. 10.1186/cc9285PubMedPubMedCentralCrossRef Koch A, Weiskirchen R, Sanson E, Zimmermann HW, Voigt S, Duckers H, Trautwein C, Tacke F: Circulating retinol binding protein 4 in critically ill patients before specific treatment: prognostic impact and correlation with organ function, metabolism and inflammation. Crit Care 2010, 14: R179. 10.1186/cc9285PubMedPubMedCentralCrossRef
24.
go back to reference Koch A, Weiskirchen R, Zimmermann HW, Sanson E, Trautwein C, Tacke F: Relevance of serum leptin and leptin-receptor concentrations in critically ill patients. Mediators Inflamm 2010, 2010: pii: 473540.CrossRef Koch A, Weiskirchen R, Zimmermann HW, Sanson E, Trautwein C, Tacke F: Relevance of serum leptin and leptin-receptor concentrations in critically ill patients. Mediators Inflamm 2010, 2010: pii: 473540.CrossRef
25.
go back to reference Suttner S, Boldt J: Prediction of sepsis after multiple trauma: does C-type natriuretic peptide do the trick? Crit Care Med 2010, 38: 323-324. 10.1097/CCM.0b013e3181bc7d50PubMedCrossRef Suttner S, Boldt J: Prediction of sepsis after multiple trauma: does C-type natriuretic peptide do the trick? Crit Care Med 2010, 38: 323-324. 10.1097/CCM.0b013e3181bc7d50PubMedCrossRef
26.
go back to reference Giamarellos-Bourboulis EJ, Mega A, Grecka P, Scarpa N, Koratzanis G, Thomopoulos G, Giamarellou H: Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med 2002, 28: 1351-1356. 10.1007/s00134-002-1398-zPubMedCrossRef Giamarellos-Bourboulis EJ, Mega A, Grecka P, Scarpa N, Koratzanis G, Thomopoulos G, Giamarellou H: Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med 2002, 28: 1351-1356. 10.1007/s00134-002-1398-zPubMedCrossRef
27.
go back to reference Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J: Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001, 164: 396-402.PubMedCrossRef Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J: Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001, 164: 396-402.PubMedCrossRef
28.
go back to reference Jaszberenyi M, Bujdoso E, Telegdy G: Effects of C-type natriuretic peptide on pituitary-adrenal activation in rats. Neuroreport 1998, 9: 2601-2603. 10.1097/00001756-199808030-00032PubMedCrossRef Jaszberenyi M, Bujdoso E, Telegdy G: Effects of C-type natriuretic peptide on pituitary-adrenal activation in rats. Neuroreport 1998, 9: 2601-2603. 10.1097/00001756-199808030-00032PubMedCrossRef
29.
go back to reference Prickett TC, Barrell GK, Wellby M, Yandle TG, Richards AM, Espiner EA: Response of plasma CNP forms to acute anabolic and catabolic interventions in growing lambs. Am J Physiol Endocrinol Metab 2007, 292: E1395-1400. 10.1152/ajpendo.00469.2006PubMedCrossRef Prickett TC, Barrell GK, Wellby M, Yandle TG, Richards AM, Espiner EA: Response of plasma CNP forms to acute anabolic and catabolic interventions in growing lambs. Am J Physiol Endocrinol Metab 2007, 292: E1395-1400. 10.1152/ajpendo.00469.2006PubMedCrossRef
30.
go back to reference McArdle CA, Olcese J, Schmidt C, Poch A, Kratzmeier M, Middendorff R: C-type natriuretic peptide (CNP) in the pituitary: is CNP an autocrine regulator of gonadotropes? Endocrinology 1994, 135: 2794-2801. 10.1210/en.135.6.2794PubMedCrossRef McArdle CA, Olcese J, Schmidt C, Poch A, Kratzmeier M, Middendorff R: C-type natriuretic peptide (CNP) in the pituitary: is CNP an autocrine regulator of gonadotropes? Endocrinology 1994, 135: 2794-2801. 10.1210/en.135.6.2794PubMedCrossRef
31.
go back to reference Igaki T, Itoh H, Suga SI, Hama N, Ogawa Y, Komatsu Y, Yamashita J, Doi K, Chun TH, Nakao K: Effects of intravenously administered C-type natriuretic peptide in humans: comparison with atrial natriuretic peptide. Hypertens Res 1998, 21: 7-13. 10.1291/hypres.21.7PubMedCrossRef Igaki T, Itoh H, Suga SI, Hama N, Ogawa Y, Komatsu Y, Yamashita J, Doi K, Chun TH, Nakao K: Effects of intravenously administered C-type natriuretic peptide in humans: comparison with atrial natriuretic peptide. Hypertens Res 1998, 21: 7-13. 10.1291/hypres.21.7PubMedCrossRef
32.
go back to reference Nishimura M, Ohtsuka K, Sakamoto M, Nanbu A, Takahashi H, Yoshimura M: Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats. J Hypertens 1998, 16: 1175-1185.PubMed Nishimura M, Ohtsuka K, Sakamoto M, Nanbu A, Takahashi H, Yoshimura M: Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats. J Hypertens 1998, 16: 1175-1185.PubMed
33.
go back to reference Inuzuka M, Tamura N, Yamada N, Katsuura G, Oyamada N, Taura D, Sonoyama T, Fukunaga Y, Ohinata K, Sone M, Nakao K: C-Type natriuretic peptide as a new regulator of food intake and energy expenditure. Endocrinology 2010, 151: 3633-3642. 10.1210/en.2010-0141PubMedCrossRef Inuzuka M, Tamura N, Yamada N, Katsuura G, Oyamada N, Taura D, Sonoyama T, Fukunaga Y, Ohinata K, Sone M, Nakao K: C-Type natriuretic peptide as a new regulator of food intake and energy expenditure. Endocrinology 2010, 151: 3633-3642. 10.1210/en.2010-0141PubMedCrossRef
34.
go back to reference Koch A, Gressner OA, Sanson E, Tacke F, Trautwein C: Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Crit Care 2009, 13: R95. 10.1186/cc7925PubMedPubMedCentralCrossRef Koch A, Gressner OA, Sanson E, Tacke F, Trautwein C: Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Crit Care 2009, 13: R95. 10.1186/cc7925PubMedPubMedCentralCrossRef
Metadata
Title
Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients
Authors
Alexander Koch
Sebastian Voigt
Edouard Sanson
Hanna Dückers
Andreas Horn
Henning W Zimmermann
Christian Trautwein
Frank Tacke
Publication date
01-02-2011
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2011
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc10007

Other articles of this Issue 1/2011

Critical Care 1/2011 Go to the issue